Brett R. Hagen
Chief Accounting Officer · Kalaris Therapeutics, Inc.
- 2024
- Mar 23, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brett R. Hagen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Srinivas Akkaraju - $6.18M in KLRS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brett R. Hagen?
Brett R. Hagen is a corporate insider, tracked as Chief Accounting Officer of Kalaris Therapeutics, Inc. (KLRS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Brett R. Hagen last file a Form 4?
The most recent primary Form 4 on record is dated 23 March 2026, one of 5 filings going back to 2024.
Has Brett R. Hagen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($16K) across all tracked filings.
